Related Experiment Videos
Erythrocyte aging in the demented elderly: a fluctuating process?
G J Bosman1, P A Van der Linden, I G Bartholomeus
1Department of Biochemistry, Faculty of Medicine, University of Nijmegen, The Netherlands. G.Bosman@bioch.kun.nl
Mechanisms of Ageing and Development
|March 24, 1998
Summary
Alzheimer's disease may not affect erythrocyte aging until later stages. Significant fluctuations in erythrocyte aging parameters in dementia patients, unlike controls, hinder diagnostic use but suggest potential biomarkers for elderly health.
Area of Science:
- Gerontology
- Neuroscience
- Hematology
Background:
- Erythrocyte aging is a complex process.
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
- Understanding erythrocyte changes in dementia is crucial for early detection and management.
Purpose of the Study:
- To investigate erythrocyte aging parameters in patients with dementia.
- To determine if erythrocyte aging disturbances are detectable in early stages of Alzheimer's disease.
- To explore the potential of erythrocyte aging characteristics as biomarkers for dementia and systemic homeostasis.
Main Methods:
- Measurement of erythrocyte aging parameters.
- Longitudinal monitoring of parameters over 15 months.
- Comparison between dementia patients and age-matched healthy controls.
Main Results:
- Alzheimer-related erythrocyte aging disturbances may only be detectable in advanced dementia stages.
- Dementia patients exhibited significant fluctuations in erythrocyte aging parameters over 15 months, unlike controls.
- This variability was independent of dementia type and stage, with its cause requiring further investigation.
Conclusions:
- Erythrocyte aging characteristics are currently unreliable for early dementia diagnosis due to significant variability.
- Aging-related erythrocyte IgG content shows promise as a sensitive biomarker for detecting disturbed systemic homeostasis in the elderly.